Literature DB >> 17389481

Novel sutureless transplantation of bioadhesive-coated, freeze-dried amniotic membrane for ocular surface reconstruction.

Eiichi Sekiyama1, Takahiro Nakamura, Eiji Kurihara, Leanne J Cooper, Nigel J Fullwood, Maho Takaoka, Junji Hamuro, Shigeru Kinoshita.   

Abstract

PURPOSE: To evaluate the efficacy and safety of a novel sutureless transplantation of bioadhesive-coated, sterilized, freeze-dried amniotic membrane (FD-AM) for ocular surface reconstruction.
METHODS: A bioadhesive-coated, freeze-dried amniotic membrane was made by freeze drying the denuded AM in a vacuum, applying the minimum amount of fibrin glue (mixture of fibrinogen and thrombin) necessary to retain adhesion on the chorionic side, and sterilizing it by gamma-radiation. The resultant AM was characterized for its biological and morphologic properties by immunohistochemical and electron microscopic examination. In addition, fibrin glue-coated, freeze-dried (FCFD) AM was transplanted onto a rabbit scleral surface without sutures, to examine its biocompatibility.
RESULTS: Immunohistochemistry of the FCFD-AM revealed that fibrinogen existed on its chorionic side, and the process of applying fibrin glue did not affect its biological and morphologic properties. Moreover, electron microscopic examination of the chorionic side of the FCFD-AM revealed tiny microfibrils (which are probably fibrinogen protofibrils), and showed that the epithelial surface of FCFD-AM consisted of intact basal lamina similar to that of FD-AM. FCFD-AM transplantation was very easily performed, and the graft adhered to the bare sclera immediately. Though the fibrinogen naturally biodegraded within 2 weeks, the FCFD-AM remained for at least 12 weeks after transplantation. Epithelialization on the FCFD-AM was achieved within 2 weeks, as was the case with FD-AM transplantation. The conjunctival epithelium on the FCFD-AM was well stratified and not keratinized, suggesting that FCFD-AM supports normal cell differentiation.
CONCLUSIONS: The FCFD-AM retained most of the biological characteristics of FD-AM. Consequently, this sutureless method of transplantation of FCFD-AM is safe, simple, and useful for ocular surface reconstruction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389481     DOI: 10.1167/iovs.06-1104

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  A fibrin gel loaded with chitosan nanoparticles for local delivery of rhEGF: preparation and in vitro release studies.

Authors:  Wenjun Zhou; Min Zhao; Yuan Zhao; Yan Mou
Journal:  J Mater Sci Mater Med       Date:  2011-03-29       Impact factor: 3.896

2.  Amniotic membrane welded to contact lens by 1470-nm diode laser: a novel method for sutureless amniotic membrane transplantation.

Authors:  Rifat Rasier; Murat Gulsoy
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

3.  Homemade lyophilized cross linking amniotic sustained-release drug membrane with anti-scarring role after filtering surgery in rabbit eyes.

Authors:  Wan Li; Wen-Jian Chen; Wei Liu; Liang Liang; Ming-Chang Zhang
Journal:  Int J Ophthalmol       Date:  2012-10-18       Impact factor: 1.779

4.  Pilot study of a glue-less, suture-less amniotic membrane for pterygium excision.

Authors:  Ezan A Kothari; Jake E Tenewitz; John R Jayman; Mont J Cartwright
Journal:  Int Ophthalmol       Date:  2022-04-01       Impact factor: 2.029

5.  Bioinspired Nanoparticulate Medical Glues for Minimally Invasive Tissue Repair.

Authors:  Yuhan Lee; Chenjie Xu; Monisha Sebastin; Albert Lee; Nathan Holwell; Calvin Xu; David Miranda Nieves; Luye Mu; Robert S Langer; Charles Lin; Jeffrey M Karp
Journal:  Adv Healthc Mater       Date:  2015-07-27       Impact factor: 9.933

Review 6.  Amniotic membrane transplantation for acute ocular burns.

Authors:  Gerry Clare; Hanif Suleman; Catey Bunce; Harminder Dua
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

7.  Augmented dried versus cryopreserved amniotic membrane as an ocular surface dressing.

Authors:  Claire L Allen; Gerry Clare; Elizabeth A Stewart; Matthew J Branch; Owen D McIntosh; Megha Dadhwal; Harminder S Dua; Andrew Hopkinson
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

Review 8.  Fibrin glue in ophthalmology.

Authors:  Anita Panda; Sandeep Kumar; Abhiyan Kumar; Raseena Bansal; Shibal Bhartiya
Journal:  Indian J Ophthalmol       Date:  2009 Sep-Oct       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.